Literature DB >> 1155615

Salt and water balance and renin activity in renal hypertension of rats.

J Möhring, B Möhring, A Philippi, E Homsy, H Orth, G Dauda, S Kazda.   

Abstract

In male Sprague-Dawley rats, renal artery constriction in the presence of an inact contralateral kidney induced sodium retention (for 2-3 wk), moderate potassium loss,elevation of blood volume (BV), and an increase in water turnover. It is suggestedthat renal artery constriction activates the renin-angiotensin-aldosterone system, resulting in disordered regulation of salt and water balance and in blood pressure (BP) elevation. Subsequently, sodium balance was reestablished in one group of hypertensive rats. The previously retained sodium was kept in the body, and BV and reninactivity remained elevated. In a second group of animals, a malignant course of hypertension developed: BP surpassed a critical level of about 180 mmHg; sodium, potassium, and water were lost; BV declined; renin activity was further stimulated; and in the contralateral kidney malignant nephrosclerosis occurred. It is assumed that pressure diuresis and natriuresis induce a vicious circle: the increasing renin activity may maintain or further increase BP level, therby inducing further salt and water loss, etc.; high BP levels and high renin activities induce vascular damage and deterioration of renal function.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1155615     DOI: 10.1152/ajplegacy.1975.228.6.1847

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  Increased Expression of Macrophage Migration Inhibitory Factor in the Nucleus of the Solitary Tract Attenuates Renovascular Hypertension in Rats.

Authors:  Rafaela Moreira Barbosa; Guilherme F Speretta; Daniel Penteado Martins Dias; Prashant Jay Ruchaya; Hongwei Li; José Vanderlei Menani; Colin Sumners; Eduardo Colombari; Débora S A Colombari
Journal:  Am J Hypertens       Date:  2017-04-01       Impact factor: 2.689

2.  Increase in plasma renin activity, water intake and blood pressure following application and reapplication of a renal artery clip.

Authors:  R G ten Berg; W de Jong
Journal:  Pflugers Arch       Date:  1980-06       Impact factor: 3.657

3.  Inhibitors of the renin-angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting-enzyme inhibitor.

Authors:  J J Morton; J Casals-Stenzel; A F Lever; J A Millar; A J Riegger; M Tree
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

4.  Salt appetite during the early phase of renal hypertension in rats.

Authors:  J Möhring; M Petri; B Möhring
Journal:  Pflugers Arch       Date:  1975-04-29       Impact factor: 3.657

5.  Increased sodium appetite and polydipsia induced by partial aortic occlusion in the rat.

Authors:  M Costales; J T Fitzsimons; M Vijande
Journal:  J Physiol       Date:  1984-07       Impact factor: 5.182

6.  Variable hemodynamic response to sodium nitroprusside in hypertensive crisis.

Authors:  G Domenighetti; C Perret
Journal:  Intensive Care Med       Date:  1982       Impact factor: 17.440

7.  The failure of furosemide-induced salt and water loss to convert benign to malignant hypertension in the rat.

Authors:  S K Wilson; K Solez; R H Heptinstall
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

8.  Predictability of surgical cure of renovascular hypertension.

Authors:  J T Rosenthal; J A Libertino; L N Zinman; D J Breslin; N W Swinton; A R Christlieb
Journal:  Ann Surg       Date:  1981-04       Impact factor: 12.969

9.  Effect of morin, a flavonoid against DOCA-salt hypertensive rats: a dose dependent study.

Authors:  P Prahalathan; S Kumar; B Raja
Journal:  Asian Pac J Trop Biomed       Date:  2012-06

10.  Angiotensin-converting enzyme i/d polymorphism in patients with malignant hypertension.

Authors:  Eugenia Espinel; Jose Luis Tovar; Javier Borrellas; Luis Piera; Rosendo Jardi; Francisco Rodriguez Frias; Luis Armadans; Ana Gonzalez Bachs
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.